TABLE 2.
Ongoing clinical trials for gut microbiota in alcoholic liver disease.
| Intervention/treatment | Patient group | Allocation/Intervention model | Trial status | Trial number |
| Enteral feeding | Alcoholic hepatitis | Case-only/observational | Active, not recruiting | NCT04544020 |
| Synbiotics (Profermin®) | Alcoholic liver disease at least F3 fibrosis | Randomized parallel assignment | Active, not recruiting | NCT03863730 |
| Probiotics (Lacidofil®) | Alcoholic hepatitis | Randomized/single group assignment | Unknown | NCT02335632 |
| Probiotics (VSL#3) | Alcoholic liver disease, alcohol use disorder | Randomized parallel assignment | Recruiting | NCT05007470 |
| Rifaximin | Alcoholic hepatitis | Non-randomized/single group assignment | Unknown | NCT02116556 |
| Rifaximin | Alcoholic hepatitis | Randomized parallel assignment | Unknown | NCT02485106 |
| Amoxicillin | Alcoholic hepatitis | Randomized parallel assignment | Completed | NCT02281929 |
| Ciprofloxacin | Alcoholic hepatitis, alcoholic cirrhosis | Randomized parallel assignment | Completed | NCT02326103 |
| Vancomycin, gentamycin, meropenem | Alcoholic hepatitis | Single group assignment | Completed | NCT03157388 |
| Fecal microbial transplantation | Alcoholic hepatitis | Randomized parallel assignment | Completed | NCT02458079 |
| Fecal microbial transplantation | Alcoholic hepatitis | Non-randomized parallel assignment | Unknown | NCT03827772 |
| Fecal microbial transplantation | Alcoholic hepatitis | Randomized parallel assignment | Unknown | NCT03091010 |
| Fecal microbial transplantation | Alcoholic hepatitis | Randomized parallel assignment | Not yet recruiting | NCT05006430 |
| Fecal microbial transplantation | Alcoholic hepatitis | Not applicable/single group assignment | Recruiting | NCT04758806 |
| Fecal microbial transplantation | Alcoholic hepatitis | Randomized parallel assignment | Not yet recruiting | NCT05285592 |